Efficacy, safety and tolerability of artesunate-mefloquine in the treatment of uncomplicated Plasmodium falciparum malaria in four geographic zones of Nigeria

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Agomo, Philip U ^a   Meremikwu, Martin M ^b   Watila, Ismaila M ^c   Omalu, Innocent J ^d   Odey, Friday A ^b   Oguche, Stephen ^d   Ezeiru, Valentine I ^e   Aina, Olugbenga O ^a  

^a NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

^b UNIVERSITY OF CALABAR   (Nigeria)

^c State Specialists Hospitals ^*  (Nigeria)

^d UNIVERSITY OF JOS   (Nigeria)

^e Oculus Pharmacare Ltd   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEQUIN; ARTESUNATE; MEFLOQUINE; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ABDOMINAL DISCOMFORT; ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACKACHE; CLINICAL TRIAL; DIZZINESS; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FEMALE; HEADACHE; HUMAN; INSOMNIA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MULTICENTER STUDY; NIGERIA; PLASMODIUM FALCIPARUM; SCHOOL CHILD; SIDE EFFECT; SPINAL PAIN; VOMITING; WEAKNESS; WORLD HEALTH ORGANIZATION; DRUG COMBINATION; MALARIA; PARASITEMIA; RURAL POPULATION; TIME;

ANTIMALARIALS; ARTEMISININS; DRUG THERAPY, COMBINATION; HUMANS; MALARIA; MEFLOQUINE; NIGERIA; PARASITEMIA; RURAL POPULATION; TIME FACTORS;

EID: 52149087679     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-172     Document Type: Article

References (24)

1. Opportunities, problems and prospects for malaria control in sub-Saharan Africa. A Teklehaimanot A Bosman, Parassitologia 1998 41 335 338
2. In vitro chloroquine and mefloquine resistant Plasmodium falciparum in Nigeria. LA Salako AF Aderounmu, Lancet 1987 2 572 573 10.1016/S0140-6736(87) 90221-2
3. Federal Ministry of Health, 2004, Abuja World Health Organization: The implementation of the global malaria control strategy: WHO Technical report series No 839, 1993, Geneva. National Antimalarial Policy
4. Sensitivity of Plasmodium falciparum to chloroquine and sulphadoxine-pyrimethamine in Nigerian children. OJ Ekanem JA Weisfeld LA Salako BL Nahlen ENU Ezedinachi O Walker JG Bremen OJ Laoye K Hedberg, Bull World Health Organ 1990 68 45 52 2189585
5. Delaying antimalarial drug resistance with combination chemotherapy. NJ White, Parassitologia 1999 41 301 308 10697872
6. Averting a malaria disaster. NJ White F Nosten S Leoreesuwan MM Watkins K Marsh RW Snow G Kokwaro J Quma TT Hien ME Molyneux TE Taylor CL Newbold TK Ruebush II M Danis BM Greenland RM Anderson P Olliaro, Lancet 1999 353 1965 1967 10.1016/S0140-6736(98)07367-X 10371589
7. Artemisinin and derivatives in the treatment of uncomplicated malaria. NJ White P Olliaro, Medicine Tropical (Mars) 1998 58 suppl 3 54 56
8. Responses of multidrug-resistant Plasmodium falciparum parasite to mefloquine in Nigerian children. JN Okoyeh L Lege-Oguntoye RO Ugbode GO Ogunrinde, Trop Med Int Health 1997 2 319 324 9171839
9. Comparative efficacy of chloroquine/chlorpheniramine combination and mefloquine for the treatment of chloroquine-resistant Plasmodium falciparum malaria in Nigerian children. A Sowunmi AMJ Oduola, Trans R Soc Trop Med Hyg 1997 91; 689 693 10.1016/S0035-9203(97)90526-5 9509181
10. Malaria infection during pregnancy and at delivery in mother, placenta and newborn: efficacy of chloroquine and mefloquine in rural Malawi. RW Steketee JJ Wirima L Slutsker JM Roberts CO Khoromana DL Heymann JG Breman, Am J Trop Med Hyg 1996 55 1 Suppl 24 32 8702034
11. Open comparison of artemether and mefloquine in uncomplicated Plasmodium falciparum hyperparasitaemia in children. A Sowunmi AMJ Oduola Ilesanmi LA Salako, Ann Trop Paediatr 1996 16 1 5 9 8787366
12. Chemotherapy of Malaria. S Bruce, World Health Organization, Geneva 2 1986
13. Clinical pharmacokinetics of mefloquine. J Karbwang NJ White, Clinical Pharmacokinetics 1990 19 264 279 10.2165/00003088-199019040-00002 2208897
14. Randomized trial of mefloquine alone and artesunate followed by mefloquine for the treatment of acute uncomplicated falciparum malaria. S Looaresuwan C Viravan S Vanijanonta P Pitisuttithum, Ann Trop Med Parasitol 1994 88 131 136 8067808
15. Artesunate - Mefloquine treatment of multi-drug resistant falciparum malaria. RN Price F Nosten G Luxemburger, Trans R Soc Trop Med Hyg 1997 91 574 577 10.1016/S0035-9203(97)90032-8 9463672
16. A randomized double-blind study on the efficacy and safety of a practical three-day regimen with artesunate and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in Africa. A Massousgbodji D Kone Kinde Gazard A same-Ekobo N Cambon EA Mueller, Trans Roy Soc Trop Med Hyg 2002 96 655 659 10.1016/S0035-9203(02)90344-5 12625145
17. Efficacy of Mefloquine and Mefloquine-Artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon region of Bolivia. JC Avila R Villaroel W Marquino J Zegarra R Mollinedo TK Ruebush, Trop Med Int Health 2004 9 217 21 10.1046/j.1365-3156.2003.01184.x 15040558
18. Effects of artesunate mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in Western Thailand; a Prospective Study. F Nosten M Van Vugt R Price C Luxemburger KL Thway A Brockman R Mcgready F ter Kuile S Looaresuwan NJ White, Lancet 2000 356 297 302 10.1016/S0140- 6736(00)02505-8 11071185
19. Clinical trials of artemisinin and its derivates in the treatment of malaria in China. GQ Li XB Guo LC Fu Hx Jean XH Wang, Trans R Soc Trop Med Hyg 1994 88 suppl 1 5 6 10.1016/0035-9203(94)90460-X
20. Assessment and monitoring of Antimalarial Drug Efficacy for the treatment of uncomplicated falciparum malaria. WHO, WHO/HTM/RBM/2003.50
21. Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug, CGP 56697. S Von S Jaffar M Pinder M Haywood G Snounou B Gemberli I Gathmann C Royce B Greenwood, J Infect Dis 1997 176 1113 1116 9333180
22. Artesunate and Mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute plasmodium falciparum malria: randomized, double-blind study in Thailand. S Krudsood S Looareesuwan U Silachamroon K Chalermrut D Pittrow N Cambon EA Mueller, Am J Trop Med Hyg 2000 67 460 472
23. Efficacy and safety of artemether - lumefantrine (Coartem®) tablets (six-dose regimen) in African infants and children with acute, uncomplicated malaria. C Falade M Makanga Z Premji C Ortmann M Stockmeyer P de Palacios, Trans R Soc Trop Med Hyg 2005 99 459 67 10.1016/j.trstmh.2004.09.013 15837358
24. Plasma macrophage colony - stimulating factor and P-selectin levels in malaria - associated thrombocytopenia. SH Lee S Looareesuwan J Chan S Wilairatana S Vanijanonta SM Chong BH Chong, Thromb Haemost 1997 77 2 289 293 9157583